NP
TMO icon

Nilsine Partners’s Thermo Fisher Scientific TMO Stock Holding History

Nilsine Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$941K Sell
1,877
-138
-7% -$66.2K 0.07% 236
2026
Q1 		$943K Sell
2,015
-652
-24% -$354K 0.07% 216
2025
Q4 		$1.55M Buy
2,667
+359
+16% +$203K 0.13% 153
2025
Q3 		$1.12M Sell
2,308
-236
-9% -$110K 0.1% 196
2025
Q2 		$1.03M Sell
2,544
-8,790
-78% -$3.68M 0.1% 196
2025
Q1 		$5.64M Buy
11,334
+669
+6% +$362K 0.62% 32
2024
Q4 		$5.55M Buy
10,665
+473
+5% +$260K 0.59% 34
2024
Q3 		$6.3M Buy
10,192
+29
+0.3% +$17.2K 0.82% 27
2024
Q2 		$5.62M Buy
10,163
+268
+3% +$154K 0.75% 31
2024
Q1 		$5.75M Buy
9,895
+265
+3% +$149K 0.79% 29
2023
Q4 		$5.11M Sell
9,630
-906
-9% -$439K 0.79% 37
2023
Q3 		$5.33M Buy
10,536
+806
+8% +$429K 0.81% 31
2023
Q2 		$5.08M Sell
9,730
-111
-1% -$59.9K 0.75% 31
2023
Q1 		$5.67M Buy
+9,841
New +$5.55M 0.89% 23

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Nilsine Partners's TMO Position: Q2 2026 in Review

Nilsine Partners reduced its Thermo Fisher Scientific (TMO) stake by 6.8% in Q2 2026, selling an estimated $66.2K and leaving 1,877 shares worth $941K. The position accounts for 0.07% of the portfolio, ranked #236.

Nilsine Partners first reported a position in TMO in Q1 2023 and has held it in 14 quarters since. The position peaked at $6.3M in Q3 2024. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Nilsine Partners held 1,877 shares of Thermo Fisher Scientific worth $941K as of Q2 2026.
  • Nilsine Partners sold 138 Thermo Fisher Scientific shares in Q2 2026, an estimated $66.2K.
  • Thermo Fisher Scientific made up 0.07% of Nilsine Partners's portfolio in Q2 2026, its #236 holding.
  • Nilsine Partners first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 14 quarters since.
  • Nilsine Partners's Thermo Fisher Scientific position peaked at $6.3M in Q3 2024.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.